Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
02/21/2025 | PUT | $30.00 | 15,000 | +15,000 | |
02/21/2025 | CALL | $30.00 | 15,000 | +15,000 | |
01/15/2027 | CALL | $27.00 | 12,358 | +8,507 | +220.90% |
11/22/2024 | PUT | $26.00 | 47,720 | +7,866 | +19.74% |
11/15/2024 | PUT | $26.50 | 12,775 | +5,838 | +84.16% |
12/06/2024 | PUT | $25.00 | 4,501 | +4,082 | +974.22% |
11/15/2024 | PUT | $27.50 | 1,644 | -981 | -37.37% |
11/22/2024 | PUT | $28.00 | 442 | -1,692 | -79.29% |
12/18/2026 | PUT | $42.00 | 3,793 | -2,000 | -34.52% |
11/15/2024 | PUT | $27.00 | 10,210 | -2,997 | -22.69% |
01/17/2025 | PUT | $30.00 | 25,635 | -3,919 | -13.26% |
11/15/2024 | PUT | $28.00 | 5,371 | -5,474 | -50.47% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
American Balanced Fund | 1.00% | 56.61M | 2.04B |
Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
11/12 02:00 am
GlobeNewswire Inc.
Read moreValneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe
11/12 02:00 am
GlobeNewswire Inc.
Read moreNeedle Free Injectors Market Is Expected To Reach a Revenue Of USD 2,980.9 Million By 2033, At 8.1% CAGR: Dimension Market Research
11/11 12:59 pm
GlobeNewswire Inc.
Read more3 Spectacular High-Yield Dividend Stocks to Buy in November
11/10 10:30 am
The Motley Fool
Read more2 Magnificent S&P 500 Dividend Stocks Down Year to Date to Buy and Hold Forever
11/09 12:21 pm
The Motley Fool
Read more2 Magnificent Stocks to Buy That Are Near 52-Week Lows
11/05 10:45 am
The Motley Fool
Read more1 Green Flag That's Also a Red Flag for Pfizer Stock
11/05 07:30 am
The Motley Fool
Read morePrediabetes Market to hit USD 360.6 million by 2032, says Global Market Insights Inc.
11/05 07:00 am
GlobeNewswire Inc.
Read more2 Sensational Growth Stocks to Buy at a Discount
11/03 12:30 pm
The Motley Fool
Read more3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
11/03 09:33 am
The Motley Fool
Read more3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think
10/31 05:41 am
The Motley Fool
Read moreIs Eli Lilly Stock a Buy?
10/30 04:40 am
The Motley Fool
Read moreWhy Pfizer Stock Tumbled on Tuesday
10/29 07:06 pm
The Motley Fool
Read moreGlobal Lung Cancer Therapeutics Market Set to Reach USD 48,725.9 Million by 2026 with an Impressive CAGR of 13.4% growth over the forecast period 2022 to 2032 | FMI
10/27 08:30 pm
GlobeNewswire Inc.
Read more3 Magnificent S&P 500 Dividend Stocks Down 43%, 20%, and 53% to Buy and Hold Forever
10/26 06:48 pm
The Motley Fool
Read more1 High-Yield Dividend Growth ETF to Buy With $30 and Hold Forever
10/26 05:32 am
The Motley Fool
Read moreBiliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - Develop Comprehensive Care Protocols & Improve Access to Treatments
10/25 10:56 am
GlobeNewswire Inc.
Read more3 Sweet Dividend Stocks to Treat Your Portfolio With This Halloween
10/25 04:40 am
The Motley Fool
Read moreCDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
10/24 02:46 pm
Benzinga
Read more5 High-Yield Dividend Stocks to Buy Without Hesitation
10/24 07:45 am
The Motley Fool
Read moreFDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
10/23 11:31 am
Benzinga
Read moreThis Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
10/21 07:45 am
The Motley Fool
Read more1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
10/21 05:49 am
The Motley Fool
Read more3 Bargain Stocks to Buy in a Market That's Priced for Perfection
10/19 07:30 am
The Motley Fool
Read moreGuggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle
10/16 08:19 am
Benzinga
Read moreSaudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - Jamjoom Pharma, Pfizer, Hikma Pharma, Fresenius, Novartis & More
10/16 04:55 am
GlobeNewswire Inc.
Read moreProstate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the Domain
10/15 01:00 pm
GlobeNewswire Inc.
Read more2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 92% in 12 Months, According to Select Wall Street Analysts
10/15 04:41 am
The Motley Fool
Read moreThese 3 Stocks Just Spiked—Buy the Rally or Sell the News?
10/14 02:46 pm
Benzinga
Read moreHemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights
10/14 12:33 pm
GlobeNewswire Inc.
Read moremRNA Cancer Vaccines and Therapeutics Research Report 2024 with Long-term Forecasts to 2028 and 2033: Personalized Medicine and Multivalent mRNA Vaccines Lead the Way
10/14 11:48 am
GlobeNewswire Inc.
Read moreBiopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments
10/14 10:58 am
GlobeNewswire Inc.
Read moreChemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030
10/14 10:54 am
GlobeNewswire Inc.
Read moreFDA Approves Pfizer's Second Hemophilia Drug With Six Months
10/14 07:35 am
Benzinga
Read more2 Incredibly Cheap Big Pharma Stocks to Buy Now
10/12 06:10 am
The Motley Fool
Read more3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now
10/12 05:26 am
The Motley Fool
Read moreCancer Vaccines Market Forecasts from 2024 to 2029: Lung and Breast Cancer Remain Key Targets, FDA Approvals for HPV and HBV Vaccines Boost Expansion
10/11 06:49 am
GlobeNewswire Inc.
Read moreNasal Drug Delivery Technology Industry Analysis and Opportunity Forecast, 2030 - Strategic Profiles of 47 Key Players in the Projected $125 Billion Market - 3M, AstraZeneca, Johnson & Johnson, Pfizer & More
10/11 04:46 am
GlobeNewswire Inc.
Read moreWhy Pfizer Stock Tumbled by Nearly 3% on Thursday
10/10 05:51 pm
The Motley Fool
Read moreGlobal Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight
10/10 01:00 pm
GlobeNewswire Inc.
Read moreStrong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this year
10/10 01:15 am
GlobeNewswire Inc.
Read moreStarke Cresemba® (Isavuconazol)-Umsätze in Asien-Pazifik und China lösen vierte Meilensteinzahlung für diese Region in diesem Jahr an Basilea aus
10/10 01:15 am
GlobeNewswire Inc.
Read moreS&P 500 Hits New All-Time High Ahead Of Fed Minutes As Lower Oil Prices Offer Relief: What's Driving Markets Wednesday?
10/09 12:03 pm
Benzinga
Read moreGermany Pharmaceuticals Market Report 2024-2028: Consolidation through Mergers and Acquisitions Catalyzing Growth
10/09 06:43 am
GlobeNewswire Inc.
Read moreAs a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?
10/09 04:55 am
The Motley Fool
Read more3 Stocks Set to Benefit from Cooling Inflation Trends
10/08 02:29 pm
Benzinga
Read more4 Reasons Pfizer Could Be a Value Play You Can't Miss
10/08 07:52 am
Investing.com
Read moreWhy Pfizer Stock Popped on Monday
10/07 12:18 pm
The Motley Fool
Read moreWall Street Set To Start New Week Sharply Lower As Traders Brace For Key Economic Data And Fed Minutes: Why Strategist Sees Market Consolidating In Near Term
10/07 06:41 am
Benzinga
Read moreAmid Pfizer's Struggles With Declining Demand For COVID-19 Treatments, Activist Investor Starboard Value Invests $1B In Pharma Giant: Report
10/06 09:49 pm
Benzinga
Read more